SCHEMBL2484009

SCHEMBL2484009

O=C(Oc1cccc(-c2ccccc2)c1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 1/20 0.55
KMT2A Q03164 7/20 0.54
MAPT P10636 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
SLC6A3 Q01959 1/20 0.53
HSD17B10 Q99714 2/20 0.51
MEN1 O00255 2/20 0.51
GAA P10253 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
ESR1 P03372 2/20 0.51
ESR2 Q92731 2/20 0.51
JAK2 O60674 1/20 0.51
USP2 O75604 1/20 0.51
ALOX15 P16050 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
LMNA P02545 2/20 0.48
METAP2 P50579 1/20 0.48
METAP1 P53582 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL150516 0.86 KMT2A (0.61) TOP1KMT2AMAPTSMN1; SMN2SLC6A3
SCHEMBL3826754 0.86 KMT2A (0.66) TOP1KMT2AMAPTSMN1; SMN2SLC6A3
SCHEMBL28123080 0.82 RXRA (0.57) TOP1KMT2AMAPTSMN1; SMN2SLC6A3
SCHEMBL6264269 0.82 HNF4A (0.53) TOP1KMT2AMAPTSMN1; SMN2SLC6A3
SCHEMBL27717755 0.82 SLC6A3 (0.55) TOP1KMT2AMAPTSMN1; SMN2SLC6A3
Hydrogen Sulfide SCHEMBL27779483 0.81 KMT2A (0.56) TOP1KMT2AMAPTSMN1; SMN2SLC6A3
SCHEMBL27944883 0.81 GAA (0.46) MAPTGAATDP1L3MBTL1LMNA
SCHEMBL2508951 0.81 MAPT (0.47) TOP1KMT2AMAPTSMN1; SMN2SLC6A3
SCHEMBL31517375 0.80 KMT2A (0.68) TOP1KMT2AMAPTSMN1; SMN2SLC6A3
SCHEMBL6883471 0.80 HNF4A (0.50) TOP1KMT2AMAPTSMN1; SMN2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT TOP1 4756/4885KMT2A 1611/4885MAPT 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.